Find and Pitch Jounalists, Get Your Story Covered

Tags: Palazestrant Phase 1b/2 Trial Future Trials

	Profile	Recent Articles on Subject
1	Sophie Putka MedPage Today Enterprise, investigative writer. New York, USA enterprise journalisminvestigative journalism	Long-Term Data Support Non-Hormonal Drug for Hot-Flash Management - 4 days ago
2	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 5 days ago Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma - 15 days ago Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - about 1 month ago Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC - 7 months ago Cabozantinib Plus Atezolizumab Delays Progression in mCRPC - 8 months ago Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBC - 9 months ago Novel Drug Makes Its Case for Pretreated Primary Biliary Cholangitis - 10 months ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - 11 months ago Pembrolizumab in First-Line Boosts PFS in HER2-Positive Stomach Cancer - 11 months ago
3	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Exploratory Analysis Shows Favorable Outcomes for Amivantamab-Lazertinib Treatment in NSCLC - 8 days ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - about 1 month ago FDA Grants Orphan Drug Designation to PT217 for Neuroendocrine Carcinoma - about 1 month ago FDA Approves Palopegteriparatide for Treatment of Hypoparathyroidism - about 1 month ago FDA Grants Orphan Drug Designation to ZMA001 for Pulmonary Arterial Hypertension - about 2 months ago Dostarlimab Plus Chemotherapy Demonstrates Significant Overall Survival Benefit in Endometrial Cancer - 6 months ago AstraZeneca to Initiate Trial for Triple-Combination Inhaled Therapy for Chronic Obstructive Pulmonary Disease - 6 months ago FDA Approves Berdazimer Topical Gel as First Treatment for Molluscum Contagiosum - 8 months ago FDA Approves Belzutifan for Treatment of Advanced Renal Cell Carcinoma - 9 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 10 months ago Prevention, Treatment for Migraine Rapidly Evolves, Calling for Development of Novel Drugs - 10 months ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - 10 months ago Domvanalimab-Containing Regimen Shows Positive Preliminary Data for Upper Gastrointestinal Cancers - 11 months ago Datopotamab Deruxtecan Demonstrates Improvement in Progression-Free Survival in HR+, HER2- Breast Cancer - 12 months ago FDA Grants Priority Review to New Drug Application for Belzutifan for Advanced Renal Cell Carcinoma - 12 months ago
4	Aislinn Antrim, Assistant Managing Editor Pharmacy Times Journalist at Pharmacy Times. UNC graduate. PoliticsStorytellingCats	FDA Grants Breakthrough Therapy Designation to Plozasiran for Familial Chylomicronemia Syndrome - 8 days ago FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Therapies - 8 months ago FDA Experts Review Data, Regulatory Insights for New Metastatic Breast Cancer Treatments - 10 months ago FDA Approves Zilucoplan for Generalized Myasthenia Gravis in AChR Antibody-Positive Adults - 11 months ago
5	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	MHRA approves Astellas’ Vyloy combination for gastric cancer - 28 days ago
6	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Fam-Trastuzumab Deruxtecan-nxki for Unresectable or Metastatic HER2-Positive Solid Tumors - 6 months ago FDA Approves Tislelizumab-jsgr for Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy - 6 months ago
7	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 6 months ago Novel Chemotherapy Method Could Decrease Lung Cancer Tumor Size - 7 months ago FDA Approves Pembrolizumab Plus Chemotherapy to Treat Metastatic HER2-Negative Gastric, Gastroesophageal Junction Adenocarcinoma - 10 months ago
8	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	FDA Grants Fast Track Designation to PT886 for the Treatment of Pancreatic Cancer - 6 months ago FDA Approves Expanded Indications for Spesolimab-sbzo Injection for the Treatment of Generalized Pustular Psoriasis - 6 months ago Risankizumab Demonstrated Superior to Apremilast for Patients With Moderate Psoriasis - 6 months ago
9	Nicole Lou MedPage Today Medical reporter @medpagetoday. Bird advocate. undisclosed remote location medical reporting	Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication - 6 months ago Drug-Coated Balloon Answers 'Embarrassing' Need for In-Stent Restenosis in U.S. - 11 months ago
10	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	FDA Approves New Frontline Regimen for Aggressive ALL - 6 months ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - 9 months ago New Oral Drug Approved for Metastatic Colorectal Cancer - 11 months ago

Journalists covering Palazestrant